Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

200297 citationsJournal Article

Authors

U. Martinowitz · National Hemophilia Foundation

Abstract

rFVIIa is a promising adjunctive hemostatic treatment for trauma patients suffering from massive bleeding. Controlled trials are warranted to evaluate the safety and efficacy of this drug.

Topics & Keywords

Hemophilia Treatment and Research Hemostasis and retained surgical items Trauma, Hemostasis, Coagulopathy, Resuscitation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 49, Issue 10, pp. S15-20

Field-Weighted Citation Impact: 4.59